Frederic Harb | Biochemistry | Research Excellence Award

Research Excellence Award

Frederic Harb
University of Balamand, Lebanon

Frederic Harb
Affiliation University of Balamand
Country Lebanon
Scopus ID 55509977300
Documents 56
Citations 462
h-index 14
Subject Area Biochemistry
Event Best Paper Awards
ORCID 0000-0001-5882-1619

This academic article summarizes the scholarly profile, research activity, and scientific contributions of Frederic Harb of the University of Balamand. The article presents a concise overview of publication performance, citation indicators, research impact, and suitability for recognition through the Research Excellence Award program.[1]

Abstract

Frederic Harb is a researcher affiliated with the University of Balamand whose academic work is primarily associated with biochemistry and related biomedical investigations. Based on available bibliometric indicators, the researcher has produced 56 indexed documents, accumulated 462 citations, and achieved an h-index of 14. These metrics indicate sustained scholarly activity and measurable influence within the scientific literature. The profile demonstrates engagement in peer-reviewed research, interdisciplinary collaboration, and knowledge dissemination. This article provides a concise assessment of research achievements, publication performance, scientific impact, and relevance to the objectives of the Research Excellence Award.[1]

Keywords

Biochemistry, Research Excellence Award, Scientific Publications, Citation Impact, Academic Recognition, Scholarly Contributions, University of Balamand, Research Assessment.

Introduction

Research evaluation commonly considers publication productivity, citation influence, and scholarly engagement. Frederic Harb has developed a documented academic profile within biochemistry, contributing to scientific literature through peer-reviewed publications and collaborative investigations. Such indicators provide a foundation for assessing research quality and academic standing.[1]

Research Profile

The researcher is affiliated with the University of Balamand in Lebanon. Bibliometric records indicate 56 indexed publications, 462 citations, and an h-index of 14. These metrics reflect continuing participation in scholarly communication and demonstrate an established presence within the academic research community.[1]

Research Contributions

Research contributions have focused on biochemistry and related scientific disciplines. Published studies contribute to understanding biological mechanisms and biomedical applications. Through collaborative investigations and peer-reviewed dissemination, the researcher has supported the advancement of scientific knowledge and promoted evidence-based research practices.[2]

Publications

The publication record includes 56 indexed documents covering diverse aspects of biochemistry. These outputs have appeared in peer-reviewed scholarly venues and contribute to scientific discourse. Publication activity demonstrates consistency in research engagement and participation in internationally recognized academic communication channels.[1]

Research Impact

Citation indicators provide evidence of research visibility and scholarly influence. With 462 citations and an h-index of 14, the researcher’s work has been referenced by other academics, demonstrating relevance within the scientific community. These metrics indicate measurable impact and ongoing recognition of published findings.[1]

Award Suitability

The available academic indicators suggest suitability for consideration within research recognition programs. Publication productivity, citation performance, and demonstrated scholarly engagement align with common evaluation criteria used by academic award committees when assessing scientific achievement and contribution to disciplinary advancement.[3]

Conclusion

Frederic Harb has established a documented research profile characterized by peer-reviewed publications, citation impact, and scientific engagement. The available evidence supports recognition of sustained academic contributions and highlights the researcher’s role in advancing biochemistry-related scholarship through scholarly communication and collaborative research activities.

References

  1. Elsevier. (n.d.). Scopus author details: Frederic Harb, Author ID 55509977300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55509977300
  2. ORCID. (n.d.). Research activities and scholarly profile of Frederic Harb.
    https://orcid.org/0000-0001-5882-1619
  3. Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease.
    https://www.mdpi.com/1422-0067/24/19/14898

  4. Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.
    https://www.mdpi.com/2077-0383/14/3/727

P. V. G. K Sarma | Biochemistry | Editorial Board Member

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.